Consultation has opened on proposals for labelling requirements for substances/groups of substances in medicines and related products that may cause an undesirable reaction (eg, allergies).
The consultation is online via a series of pages. You can choose to provide feedback on some or all of the proposed statements, and in any order.
The consultation process closes 8 August and submissions are only accepted online.
Date posted: 2 July, 2019